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Abstract 
This paper questions whether bioethical scrutiny has been devoted to the ethical dilemmas that have 
arisen with advancements of CRISPR-Cas 9 gene editing techniques, particularly its use in 
conjunction with gene drive applications. Therefore, the trend of genetic research using both gene 
drives and CRISPR-Cas 9 systems must be established, while also simultaneously observing the 
trend of bioethical scholarly works. The tabulation of all articles from 2012 to 2015 from selected 
genetic journals yielded a significant increase in articles relating to CRISPR, while no articles were 
found in their selected bioethical counterparts for the same period. Similarly, no significant 
CRISPR/gene drive research was reported in selected journals during the specified period in either 
field of study. To demonstrate trends outside of bioethical scholarship, a secondary keyword analysis 
detailed an increase in articles devoted to exploring the ethical implications of CRISPR in all fields, 
yet without additional research outside of the scope of this paper, no conclusions can be made. In 
light of the profound impact of CRISPR-Cas 9 research, the scientific and the ethical concerns of 
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Removable Discontinuity: CRISPR, Gene Drives, and Bioethics 
To fully appreciate the discoveries, ramifications, and quandaries associated with CRISPR-
Cas 9 Systems and their use with gene drives, we need to know what they are, how they came to be, 
and why exactly we should care if they are used together. To that end, this paper will have four 
distinct parts: background, methodology, findings, and discussion. The background section seeks to 
introduce, inform, and contextualize the subject matter from a layman's perspective. The 
methodology section will detail the qualitative parameters used to answer this paper’s underlying 
hypothesis, and the findings section will detail and draw conclusions from the data through the 
aforementioned methodological lens. Finally, the discussions section focuses on the limitations of 
this study and methodological protocols performed.  
Background 
CRISPR-Cas Systems. So, what exactly is a CRISPR-Cas system? The CRISPR-Cas system 
(or Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR Associated Proteins) is a 
bacterial and archaeal defense mechanism, which is conceptually analogous to our own adaptive 
immune system, that is being cleverly co-opted for use in genetic engineering labs. There are 
currently three main types of CRISPR-Cas systems that are designated by signature proteins, but for 
the purposes of this paper we will focus on type II or Cas 9 systems (Makarova et al., 2011). The 
simplified anatomy of a CRISPR locus consists of tracrRNA (trans-activating CRISPR-RNA), four 
protein coding cas genes, a leader sequence, and a CRISPR array.  CRISPR arrays are short 
palindromic units of repeating prokaryotic DNA interspaced with encoded genetic sequences 
identical to invading mobile genetic elements (MGE), like foreign viral DNA (Oost, Westra, 
Jackson, & Wiedenheft, 2014; Brouns et al., 2008).  
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The CRISPR-Cas system acquired defense is mounted in three steps: acquisition, expression, 
and interference (Dupuis, Villion, Magadán, & Moineau, 2013; Oost, 2014). After the initial 
invasion of foreign DNA and the response of restriction-modification systems (R-M systems), in 
which endonucleases cleave any foreign DNA with the appropriate recognition site, the CRISPR-
Cas system creates a protospacer of the invader. With the help of a protospacer adjacent motif 
(PAM), which is a short sequence of 3-5 base pairs that may dictate repeat length and act as red flag 
for Cas proteins to indicate a “non-self” segment in need of cutting, the CRISPR locus is extended at 
the lead end (Bolotin, Quinquis, Sorokin, & Ehrlich, 2005; Mojica, Diez-Villaseñor, García-
Martínez, & Almendros, 2009; Oost et al., 2014).  After a new spacer has been integrated into the 
CRISPR locus, the cell effectively has a working memory of past aggressors, which is the basis of its 
conferred immunity. During expression, CRISPR sequences are transcribed into segments of 
tracrRNA and pre-crRNA that, after a cleavage of their double strands by ribonuclease III, are 
associated with a Cas 9 protein, forming a Cas9-RNP complex (Oost et al., 2014). This search-and-
destroy protein complex seeks out any DNA sequences that complement its RNA cargo and runs 
interference by cutting offending DNA, thereby invalidating the threat. 
The story of CRISPR as a fully realized process began officially with the publication of three 
separate papers in 2005, which unified and detailed the characteristics of the CRISPR locus. (Bolotin 
et al., 2005; Lander., 2016; Mojica, Díez-Villaseñor, García-Martínez, & Soria, 2005; Pourcel, 
Salvignol, & Vergnaud, 2005). Overtime and through much research, a clearer picture of the 
CRISPR-Cas 9 system and its function within the cell began to coalesce. In 2007, it was proposed 
that CRISPR-Cas systems were a kind of adaptive immunity, and research the next year supported 
this hypothesis as CRISPR spacers were sequenced and viral complements confirmed (Barrangou et 
al., 2007; Bolotin et al., 2008; Lander., 2016). Further research showed that CRISPR targets DNA, 
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that Cas 9 creates targeted breaks at precise points, and that the tracrRNA and crRNA duplex are 
what guides Cas 9 to its targets (Deltcheva et al., 2011; Gasiunas, Barrangou, Horvath, & Siksnys, 
2012; Lander., 2016). Interestingly, researchers found that type II CRISPR-Cas systems are 
heterologous, or independently functional in bacteria in which it is not naturally occurring 
(Sapranauskas et al., 2011; Lander., 2016). In 2012 two separate labs, including that of the now well 
known Jennifer Doudna, discovered that Cas 9’s ability to cut target DNA could be used as a tool for 
precise gene editing in a wide variety of organisms (Gasiunas et al., 2012; Jinek et al., 2012; 
Lander., 2016). Finally, a paper published a year later confirmed that Cas 9 is functional in 
eukaryotic cells, and that multiple sites can be targeted for incision (Cong et al., 2013; Lander., 
2016). 
So, how does CRISPR-Cas 9 actually work as a gene editing tool? It turns out that a 
derivation of pre-crRNA called mature crRNA, and the previously mentioned tracrRNA are guides 
that are responsible for informing the Cas 9 protein where to make its DNA cleavages (Jinek et al., 
2014). When coaxed, these two guides can be engineered into a single reprogrammable “RNA 
chimera” (Jinek et al., 2014), which is encoded with a complementary base pair sequence and the 
guide to be inserted. Once the target sequence is found, Cas 9 can be programmed to do one of two 
things: completely cleave the target DNA, rendering it nonfunctional, or nick the target strand and 
provide a template of homologous DNA for integration.  
 CRISPR-Cas 9 is an extremely adaptive tool that is relatively easy to use, precise, and cheap. 
Scientists have yet to discover an organism in which it is non-functional. It is being used in 
everything from vector reduction research to modifying mushrooms to reduce browning (Gantz, 
2015; Waltz, 2016). It is a powerful tool that will invariably shape future generations.   
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Gene Drives. The scientific world's awareness of gene drives is not new. However, the 
conjunctive use of CRISPR-Cas 9 technologies to direct and refine synthetic gene drives is novel. 
What are genes drives exactly? They are a naturally occurring process in which selfish genetic 
elements’ chances of heritability are increased. In the context of bioengineering, synthetic gene 
drives are a co-opted process that “drives” a particular gene and biases inheritance to greater than 
50% heritability in sexually reproducing organisms, despite relative fitness (Burt, 2003). The 
precise, cheap, and simple gene editing power of CRISPR-Cas 9 Systems coupled with a synthetic 
gene drive’s generational effects mean that, theoretically, an entire population can be altered given 
time---which is sort of a big deal (Esvelt, Smidler, Catteruccia, & Church, 2014).   
Bioethics. For the duration of this paper, bioethics will be defined as the study of ethical 
quandaries that arise from developments and emerging technologies in the biological sciences. It is 
important because of its role as a translator and conduit between researchers and the general public.  
The treatment of CRISPR technologies by bioethics will inform the public's perception of this 
groundbreaking research, which will in turn inform the research.   
Method 
Original Methodology 
This paper's methodological protocol will consist of the tabulation of all articles published by 
the top 5 journals within each area of study from 2012 to 2015. Each journal will then be analyzed to 
determine the percentage of articles relating to advances in CRISPR-Cas 9 and gene drive-Cas9 
research. This approach seeks to plainly illustrate the magnitude of CRISPR-Cas 9’s role in current 
research, as well as determine whether a scholarly response has been mounted by the bioethical 
community to address quandaries that have emerged as CRISPR-Cas 9 has become more prolific. 
REMOVABLE DISCONTINUITY: CRISPR AND BIOETHICS    7 
 
Journal selection. Journal citation metrics are a family of accepted indicators which seek to 
quantify the impact of scholarly journals. Each indicator stresses a different aspect of journal 
worthiness, from average citations for a given period to perceived respectability of contributors. The 
SNIP (source normalized impact factor per paper) indicator measures the average citation impact of 
a journal, while also normalizing any publication differences between fields of study (Moed, 2010). 
Powered by the Scopus database, the SNIP indicator is a part of an easy-to-use and openly accessible 
toolkit, making it a logical choice within the scope of this paper. The first 5 journals to exhibit the 
appropriate traits under the selected subject filters (Genetics and Health Policy) were included: 
Criteria for Genetic Journal Exclusion: Non-representative biological focus (i.e. 
biochemistry, evolutionary biology, bio 
medicine) 
 
Too much specificity (i.e. cytokine and growth 
factor reviews) 
 
Reviews (i.e. annual, or a review of journal) 
Criteria for Bioethics Journal Exclusion: Medical policy, law, or health care trade journal 
 
Review (i.e. annual, or a review of journal) 
 





Journal analysis. Each journal will be analyzed on a per year basis; method of analysis 
includes a manual review and a keyword search of every volume and issue within the given 
timeframe. All articles whose subject and or methodology include CRISPR were considered as a part 
of each journal’s citable total.   
Additional Methodology 
To demonstrate trends outside of bioethical scholarship, a secondary keyword 
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analysis was performed. Previous citation standards and exclusionary parameters were dropped in 
favor of a simple key phrase search (i.e. ethical implications + CRISPR) within the previously 




Table 1. Most Impactful Genetic Journals and Table 2. Most Impactful Bioethical Journals 
are tabulations of data acquired using the original methodology. They are a complete compilation of 
total citable articles published, along with the number of articles relating to CRISPR found in the top 
5 genetic and bioethical journals for 2012 to 2015.  
Table 1. Most Impactful Genetic Journals  
Year Ranking Total Articles Genetics: CRISPR 
2015 1 732 13 
 2 206 1 
 3 820 4 
 4 617 17 
 5 4189 79 
    
2014 1 831 2 
 2 736 4 
 3 194 0 
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 4 639 12 
 5 3989 65 
    
2013 1 709 1 
 2 849 5 
 3 182 0 
 4 616 2 
 5 748 4 
    
2012 1 693 0 
 2 157 0 
 3 808 1 
 4 608 3 
 5 768 0 
 
Table 2. Most Impactful Bioethical Journals 
Year Ranking Total Citable Articles: Bioethics Bioethics: CRISPR 
2015 1 181 0 
 2 73 0 
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 3 58 0 
 4 225 0 
 5 75 0 
    
2014 1 179 0 
 2 57 0 
 3 211 0 
 4 68 0 
 5 73 0 
    
2013 1 23 0 
 2 53 0 
 3 165 0 
 4 175 0 
 5 78 0 
    
2012 1 166 0 
 2 1 0 
 3 55 0 
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 4 71 0 
 5 152 0 
  
The following is a graphical representation of the data in Table 1. The Tabulation of Most Impactful 
Genetics Journals, which depicts the trend over time more concisely than a simple table. The graph 
excludes bioethical journal data, because there were no CRISPR articles to graph.  
Graph 1. Genetic Journal Data 
 
Conclusions drawn from results of original methodology. These findings are an indication 
of bioethical focus on CRISPR for a snapshot of time under tightly controlled circumstances. 
Clearly, the data acquired using the original methods described indicates that scholarly bioethical 
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scrutiny was not being allotted for the consideration of CRISPR research from 2012 to 2015 in the 
field’s most impactful journals.    
Additional Methodology 
 Table 3. Keyword Analysis and Graph 2. Keyword Analysis Data shows the results of the 
secondary methodology performed to show the trend in scholarly dialogue across all fields of study.   
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Conclusions drawn from results of secondary methodology. This secondary research 
protocol gives a simple, yet clear picture of the prevalence of articles from 2012 to 2015 that 
included, in any capacity, the ethical implications of CRISPR. This analysis finds that as the 




 The limitations of this investigation stem from bioethics’ amorphous nature, the limited time 
frame of available journal data, and the state of research during said period. 
Defining bioethics. There is no true standardized purview for the field of bioethics. This has 
been a boon for this paper’s flexible treatment of bioethics as a large, young, and easily manipulated 
field. However, these same qualities do not lend themselves to specific and stringent peer-review. 
Finding trusted bioethics journals outside of the realm of medical research was challenging.  
Methodology. The most comprehensive and accurate journal metrics had impact factor data 
up to and including 2015. Unfortunately, though CRISPR was a very exciting prospect in the 
selected time frame, the addition of another year may have painted a more representative picture of 
its treatment by bioethics. Additionally, it may also have emphasized the proliferation of CRISPR- 
Cas 9 in the world of scientific research. 
Research landscape. The use of synthetic gene drives in conjunction with CRISPR-
Cas 9 technologies as a means of altering vector populations has only been speculated about 
since 2014 (Esvelt et al., 2014).  The time frame constraints mentioned previously also 
hindered the exploration of the questions that gene drive research poses, as there were no 
articles exploring this subject in the 5 most impactful journal during the given period. 
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Implications 
This paper sought to determine if there were any communication discontinuities between 
bioethics scholars and researchers using CRISPR-Cas 9 technologies, the results of which confirmed 
a disjuncture between the two during the selected period. The success of future research will depend 
on public perception, as this technology will have far reaching implications. The most obvious step 
forward is to simply put scholarly energy, both scientific and bioethical, towards addressing any 
ethical quandaries that have arisen and will crop up in future. With concerted effort, the 
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